3-5
2026
影响因子区间
—
平台估算
12%
2025
中国作者发文占比
3990 USD;3030 GBP;3400 EUR
收费
期刊简介:Clinical and Translational Science (CTS), an official journal of the American Society for Clinical Pharmacology and Therapeutics, highlights original translational medicine research that helps bridge laboratory discoveries with the diagnosis and treatment of human disease. Translational medicine is a multi-faceted discipline with a focus on translational therapeutics. In a broad sense, translational medicine bridges across the discovery, development, regulation, and utilization spectrum. Research may appear as Full Articles, Brief Reports, Commentaries, Phase Forwards (clinical trials), Reviews, or Tutorials. CTS also includes invited didactic content that covers the connections between clinical pharmacology and translational medicine. Best-in-class methodologies and best practices are also welcomed as Tutorials. These additional features provide context for research articles and facilitate understanding for a wide array of individuals interested in clinical and translational science. CTS welcomes high quality, scientifically sound, original manuscripts focused on clinical pharmacology and translational science, including animal, in vitro, in silico, and clinical studies supporting the breadth of drug discovery, development, regulation and clinical use of both traditional drugs and innovative modalities.
【译文】临床转化科学(CTS),是美国临床药理学和治疗学协会的官方期刊,强调有助于将实验室发现与人类疾病的诊断和治疗联系起来的原创转化医学研究。转化医学是一个多方面的学科,重点关注转化治疗。从广义上讲,转化医学跨越了发现、开发、监管和利用的全谱。研究可能以全文文章、简报、评论、临床试验(阶段向前)、综述或教程的形式出现。CTS还包括邀请的教程内容,涵盖临床药理学和转化医学之间的联系。最佳方法与实践也欢迎作为教程。这些附加功能为研究文章提供背景,并促进对临床和转化科学感兴趣的广泛个人的理解。CTS欢迎高质量的、科学可靠的、专注于临床药理学和转化科学的原创稿件,包括动物、体外、计算机模拟和临床研究,支持传统药物和创新方法的药物发现、开发、监管和临床使用。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q2 | 暂无 |
| 中科院分区 | 3区 | 暂无 |
| 影响因子区间 | 3-5 | 暂无 |